Exact Sciences Corporation (EXAS) has a consensus analyst rating of Buy, based on 41 analysts covering the stock. Of those, 22 recommend buying, 17 recommend holding, and 2 recommend selling.
The analyst consensus price target for EXAS is $103.18, representing a -1.6% downside from the current price of $104.91. Price targets range from a low of $85.00 to a high of $105.00.
